SXI Standex International

• $502K bought by 2 insiders
• $2.9M sold by 6 insiders outside a trading plan
• $7.7M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Thomas E Chorman Director
   Planned sale
   $14K 50 shares at $271.39 0.4% of stake
   Traded Oct 1 Filed Oct 2
   ↗
3. Max Arets VP; Chief Information Officer
   Buy
   $12K 45 shares at $273.96 +2.8% to stake
   Traded Sep 4 Filed Sep 9
   ↗
4. Thomas E Chorman Director
   Planned sale
   $14K 50 shares at $284.89 0.4% of stake
   Traded Sep 1 Filed Sep 3
   ↗
5. David A. Dunbar CEO
   Planned sale
   $3.8M 13,000 shares at $290.82 15% of stake
   Traded Aug 31 Filed Sep 1
   ↗
6. Alan J Glass Vice President
   Sale
   $422K 1,391 shares at $303.19 5.8% of stake
   Traded Aug 24 Filed Aug 26
   ↗
7. Ademir Sarcevic CFO
   Sale
   $704K 2,300 shares at $306.13 24% of stake
   Traded Aug 24 Filed Aug 26
   ↗
8. Thomas E Chorman Director
   Planned sale
   $15K 50 shares at $305.56 0.4% of stake
   Traded Aug 3 Filed Aug 4
   ↗
9. Thomas E Chorman Director
   Planned sale
   $18K 50 shares at $355.51 0.4% of stake
   Traded Jul 1 Filed Jul 2
   ↗
10. Barbara Joanne Edwards Director
    Sale
    $47K 150 shares at $311.05 100% of stake
    Traded Jun 16 Filed Jun 22
    ↗
11. Thomas E Chorman Director
    Planned sale
    $14K 50 shares at $272.82 0.4% of stake
    Traded Jun 1 Filed Jun 3
    ↗
12. Barbara Joanne Edwards Director
    Sale
    $153K 558 shares at $274.81 9% of stake
    Traded May 27 Filed May 28
    ↗
13. Thomas E Chorman Director
    Planned sale
    $13K 50 shares at $268.43 0.4% of stake
    Traded May 1 Filed May 4
    ↗
14. Thomas E Chorman Director
    Planned sale
    $13K 50 shares at $257.94 0.4% of stake
    Traded Apr 1 Filed Apr 3
    ↗
15. Thomas E Chorman Director
    Planned sale
    $13K 50 shares at $259.00 0.4% of stake
    Traded Mar 2 Filed Mar 3
    ↗
16. Thomas E Chorman Director
    Sale
    $133K 513 shares at $260.00 3.9% of stake
    Traded Feb 27 Filed Mar 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 share withholdings for taxes, 21 option exercises, 7 gifts, and 6 stock grants.